Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma (A231602CD)

For a patient to be eligible for participation in this study, all of the following criteria must apply.

• Patients must have current diagnosis of chronic lymphocytic leukemia (CLL) or multiple myeloma (MM)
• Patients' medical records must be available to the registering institution
• Eligible patients must have been prescribed drug-based anticancer therapy, whether administered orally or by infusion, within the prior 12 months. Specifically, eligible patients are those who:
  • Are presently being treated with infused or orally-administered anticancer therapy, OR
  • Completed infused or orally-administered anti-cancer therapy in the past 12 months, OR
  • Were prescribed infused or orally-administered anticancer therapy within the prior 12 months yet chose to forego treatment
• Not currently enrolled in a clinical trial in which drug is supplied by the study
• Patients with psychiatric illness or other mental impairment that would preclude their ability to give informed consent or to respond to the telephone survey are not eligible
• Patients must be able to read and comprehend English or Spanish

To learn more, visit ClinicalTrials.Gov

Study Type

Observational

Principal Investigator(s)

James D. Bearden III, MD